Amber Bio
Jacob Borrajo is the Co-Founder & CEO of Amber Bio. Prior to this, Jacob held positions at Alix Ventures, Coral, Broad Institute of MIT and Harvard, Scribio, MIT Media Lab, UCLA, and Harvard Medical School. Jacob holds a PhD in Biological Engineering from Massachusetts Institute of Technology, a Co-Founder degree from Y Combinator, and a BS in Chemical and Biomolecular Engineering from UCLA. Borrajo has expertise in CRISPR-Cas systems, machine learning, synthetic biology, and various engineering fields.
This person is not in any teams
This person is not in any offices
Amber Bio
2 followers
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.